Laurel Wealth Advisors (California)’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$457K	Hold	6,121	–	–	0.05%	378
2022 Q3	$506K	Hold	6,121	–	–	0.05%	337
2022 Q2	$582K	Sell	6,121 -900	-13%	-$93.2K	0.06%	324
2022 Q1	$827K	Sell	7,021 -52	-0.7%	-$5.83K	0.07%	284
2021 Q4	$916K	Buy	7,073 +1,552	+28%	+$181K	0.07%	280
2021 Q3	$625K	Sell	5,521 -1,544	-22%	-$176K	0.11%	203
2021 Q2	$731K	Hold	7,065	–	–	0.09%	216
2021 Q1	$590K	Hold	7,065	–	–	0.09%	219
2020 Q4	$645K	Buy	7,065 +144	+2%	+$11.9K	0.09%	203
2020 Q3	$553K	Hold	6,921	–	–	0.09%	211
2020 Q2	$479K	Hold	6,921	–	–	0.09%	224
2020 Q1	$435K	Sell	6,921 -300	-4%	-$21.6K	0.1%	219
2019 Q4	$562K	Buy	7,221 +150	+2%	+$11.7K	0.09%	226
2019 Q3	$518K	Buy	7,071 +1,281	+22%	+$90K	0.09%	239
2019 Q2	$357K	Sell	5,790 -1,107	-16%	-$66.9K	0.08%	271
2019 Q1	$440K	Buy	6,897 +1,485	+27%	+$84.7K	0.11%	209
2018 Q4	$276K	Buy	5,412 +300	+6%	+$15.2K	0.08%	263
2018 Q3	$296K	Hold	5,112	–	–	0.07%	280
2018 Q2	$248K	Hold	5,112	–	–	0.07%	305
2018 Q1	$237K	Buy	+5,112	New	+$222K	0.07%	286